Dr. Reddy's Laboratories Files 6-K Report
Ticker: RDY · Form: 6-K · Filed: Apr 8, 2026 · CIK: 0001135951
Sentiment: neutral
Topics: foreign-issuer, regulatory-filing
TL;DR
DRL filed a 6-K, standard report, no major news.
AI Summary
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on April 8, 2026, reporting information as of April 7, 2026. The filing includes standard report documents and exhibits, with no specific financial transactions or material events detailed in the provided text.
Why It Matters
This filing serves as a routine update for foreign issuers, providing transparency to investors about the company's ongoing operations and regulatory compliance.
Risk Assessment
Risk Level: low — The filing is a routine 6-K report with no indication of significant financial changes or material events.
Key Players & Entities
- DR REDDYS LABORATORIES LTD (company) — Filer
- 0001135951 (company) — CIK number for Dr. Reddy's Laboratories Ltd.
- 0001575872-26-000236 (filing_id) — SEC Accession Number
- 2026-04-08 (date) — Filing Date
- 2026-04-07 (date) — Period of Report
FAQ
What type of SEC filing is this?
This is a Form 6-K, which is a report of a foreign issuer.
Who is the filer of this report?
The filer is DR REDDYS LABORATORIES LTD.
What is the CIK number for Dr. Reddy's Laboratories Ltd.?
The CIK number is 0001135951.
On what date was this filing accepted by the SEC?
The filing was accepted on 2026-04-08.
What period does this report cover?
The period of the report is 2026-04-07.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 8, 2026 regarding DR REDDYS LABORATORIES LTD (RDY).